Impact of IPT With Sulfadoxin Pyrimetamin on Pregnant Women and Their Babies Outcomes in Peri-urban Areas of Bobo-Dioulasso(Burkina Faso)
NCT ID: NCT01255605
Last Updated: 2012-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
772 participants
OBSERVATIONAL
2010-09-30
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating the Effects of Community Delivery of Malaria Intermittent Preventive Treatment on Pregnant Women and Babies
NCT03600844
New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa
NCT00730366
Different Approaches for Delivery of IPT in Pregnancy in Burkina Faso
NCT00494416
Evaluation of SP Resistance and Effectiveness of IPTp in Nigeria
NCT01636895
Perennial Malaria Chemoprevention (PMC) in Côte D'Ivoire
NCT05856357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having agreed to give free and informed consent
Exclusion Criteria
* eclampsia
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université Polytechnique de Bobo-Dioulasso
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Mamoudou Cisse
Medical doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mamoudou Cisse, MD
Role: PRINCIPAL_INVESTIGATOR
Centre MURAZ Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Supérieur des Sciences de la Santé/Université Polytechnique de Bobo-Dioulasso
Bobo-Dioulasso, Houet, Burkina Faso
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PIC/INSSA/UPB-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.